Publications database

  Filter by
 

Publication date

Series / Type

Language

Main subject

Keywords

Displaying 1 - 20 of 53
Technical reports

Technical implementation and update of the European Union databank on national population surveys on drug use and carrying out a joint analysis of data collected

December 2002

This report describes the implementation of the NPSD-EU (European Union databank on national population surveys on drug use) in 2002, a database for collecting and harmonising existing national surveys on drugs. The report also presents two cross-national joint analyses carried out on the basis of...
Drugnet Europe

Drugnet Europe 38

November 2002

Drugnet Europe, the EMCDDA's quarterly newsletter, provides regular information on the Agency's activities to a broad readership. The newsletter aims to offer a complete overview of the work of the Agency and its key partners and carries features on the activities of the national focal points,...
Drugs in focus

Recreational drug use — a key EU challenge

November 2002

In nightlife settings, most people who consume psychoactive substances do so with the intention of 'having fun'. Reducing the risks run by the growing numbers of mainstream young people in the EU who consume such substances in such settings, is a key concern of policymakers at local, national and...
European Drug Report

2002 Annual report on the state of the drugs problem in the European Union and Norway

October 2002

The report on the state of the drugs problem in Europe presents the EMCDDA's yearly overview of the drug phenomenon. This is an essential reference book for policy-makers, specialists and practitioners in the drugs field or indeed anyone seeking the latest findings on drugs in Europe. Published...
European Drug Report

2002 Annual report on the state of the drugs problem in the candidate CEECs

October 2002

The report on the state of the drugs problem in Europe presents the EMCDDA's yearly overview of the drug phenomenon. This is an essential reference book for policy-makers, specialists and practitioners in the drugs field or indeed anyone seeking the latest findings on drugs in Europe. Published...
Selected issues

Successful treatment

October 2002

In the EU action plan on drugs (2000–04), the third strategy target is 'to increase substantially the number of successfully treated addicts'. No aggregated data exist at European level to directly measure the level of achievement of this objective. However, many evaluations have been carried out...
Selected issues

Polydrug use

October 2002

The broad definition of ‘polydrug’ used by many Member States is the use of more than one drug or type of drug by an individual — consumed at the same time or sequentially (as defined in the WHO lexicon). In Europe, the concept of polydrug use dates back to the 1970s. In its broadest terms,...
Selected issues

Drug use in prison

October 2002

The presence of drugs and drug use has fundamentally changed the prison reality over the past two decades and, nowadays, all countries in Europe experience major problems due to drugs and drug-related infectious diseases in prisons.
National reports

National report 2002: Austria

October 2002

Commissioned each year by the EMCDDA and produced by the national focal points of the Reitox network, the National reports draw an overall picture of the drug phenomenon at national level in each EU Member State. These data are key information to the EMCDDA and are an important resource, among...
National reports

National report 2002: United Kingdom

October 2002

Commissioned each year by the EMCDDA and produced by the national focal points of the Reitox network, the National reports draw an overall picture of the drug phenomenon at national level in each EU Member State. These data are key information to the EMCDDA and are an important resource, among...
National reports

National report 2002: Belgium

October 2002

Commissioned each year by the EMCDDA and produced by the national focal points of the Reitox network, the National reports draw an overall picture of the drug phenomenon at national level in each EU Member State. These data are key information to the EMCDDA and are an important resource, among...
National reports

National report 2002: Sweden

October 2002

Commissioned each year by the EMCDDA and produced by the national focal points of the Reitox network, the National reports draw an overall picture of the drug phenomenon at national level in each EU Member State. These data are key information to the EMCDDA and are an important resource, among...
National reports

National report 2002: Spain

October 2002

Commissioned each year by the EMCDDA and produced by the National focal points of the Reitox network, the National reports draw an overall picture of the drug phenomenon at national level in each EU Member state. These data are key information to the EMCDDA and are an important resource, among...
National reports

National report 2002: Slovenia

October 2002

Commissioned each year by the EMCDDA and produced by the National focal points of the Reitox network, the National reports draw an overall picture of the drug phenomenon at national level in each EU Member state. These data are key information to the EMCDDA and are an important resource, among...
National reports

National report 2002: Romania

October 2002

Commissioned each year by the EMCDDA and produced by the National focal points of the Reitox network, the National reports draw an overall picture of the drug phenomenon at national level in each EU Member state. These data are key information to the EMCDDA and are an important resource, among...
National reports

National report 2002: Poland

October 2002

Commissioned each year by the EMCDDA and produced by the national focal points of the Reitox network, the National reports draw an overall picture of the drug phenomenon at national level in each EU Member State. These data are key information to the EMCDDA and are an important resource, among...
National reports

National report 2002: Norway

October 2002

Commissioned each year by the EMCDDA and produced by the national focal points of the Reitox network, the National reports draw an overall picture of the drug phenomenon at national level in each EU Member State. These data are key information to the EMCDDA and are an important resource, among...
National report 2002: Netherlands
National reports

National report 2002: Netherlands

October 2002

Commissioned each year by the EMCDDA and produced by the national focal points of the Reitox network, the National reports draw an overall picture of the drug phenomenon at national level in each EU Member State. These data are key information to the EMCDDA and are an important resource, among...
National reports

National report 2002: Ireland

October 2002

Commissioned each year by the EMCDDA and produced by the national focal points of the Reitox network, the National reports draw an overall picture of the drug phenomenon at national level in each EU Member State. These data are key information to the EMCDDA and are an important resource, among...
National reports

National report 2002: Luxembourg

October 2002

Commissioned each year by the EMCDDA and produced by the national focal points of the Reitox network, the National reports draw an overall picture of the drug phenomenon at national level in each EU Member State. These data are key information to the EMCDDA and are an important resource, among...

Loading